Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Change in Acquisitions & Divestments (2023 - 2026)

Prokidney's (PROK) quarterly Change in Acquisitions & Divestments came in at $48.7 million in Q2 2026, down 24.38% year-over-year from $64.4 million in Q2 2025, and down 41.61% quarter-over-quarter from $83.4 million in Q1 2026.

Analysis

Prokidney (PROK) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends

Prokidney (PROK) has reported Change in Acquisitions & Divestments for 4 consecutive years, with $48.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 24.38% year-over-year to $48.7 million in Q2 2026; TTM through Jun 2026 was $300.8 million, a 14.48% decrease from a year earlier, with the FY2025 full-year figure at $318.0 million, down 14.96% from the prior year.
  • Change in Acquisitions & Divestments was $48.7 million for Q2 2026 at Prokidney, down from $83.4 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $115.2 million in Q3 2024 and troughed at $6.4 million in Q1 2023.
  • A 4-year average of $71.4 million and a median of $70.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
  • Across the five-year window, Change in Acquisitions & Divestments soared 1689.99% in 2024 and plunged 35.83% in 2025, its largest moves.
  • Over 4 years, Change in Acquisitions & Divestments stood at $75.6 million in 2023, then advanced by 15.46% to $87.3 million in 2024, then plunged by 35.83% to $56.0 million in 2025, then decreased by 13.13% to $48.7 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $48.7 million (Q2 2026), $83.4 million (Q1 2026), and $56.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Prokidney 346.07 Mn 346.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.67 Mn
Mar 31, 2026 83.37 Mn
Dec 31, 2025 56.03 Mn
Sep 30, 2025 112.75 Mn
Jun 30, 2025 64.37 Mn
Mar 31, 2025 84.87 Mn
Dec 31, 2024 87.32 Mn
Sep 30, 2024 115.18 Mn
Jun 30, 2024 56.67 Mn
Mar 31, 2024 114.77 Mn
Dec 31, 2023 75.63 Mn
Sep 30, 2023 39.42 Mn
Jun 30, 2023 54.36 Mn
Mar 31, 2023 6.41 Mn